BiostockMedCap Reports Q4 Results
The company delivered organic growth and acquisition-driven expansion in the fourth quarter. Adjusted EBITA rose by 68% to SEK 112.9 million (67.4), adjusted for items affecting comparability. This growth reflects positive development in the underlying business operations.